![Richard Kopke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Richard Kopke is the founder of Otologic Pharmaceutics, Inc. He held the title of Chief Medical Officer at the company, and was involved in job functions related to founding and serving as the Chief Technology Officer.
Postes actifs de Richard Kopke
Sociétés | Poste | Début |
---|---|---|
Otologic Pharmaceutics, Inc.
![]() Otologic Pharmaceutics, Inc. Pharmaceuticals: MajorHealth Technology Otologic Pharmaceutics, Inc. develops treatment for acute hearing loss. Its product HPN1010 is an oral medication to treat acute hearing loss to reduce the development of permanent hearing disorders. The company was founded by Richard Kopke, Robert A. Floyd and Dave karlman and is headquartered in Oklahoma City, OK. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Otologic Pharmaceutics, Inc.
![]() Otologic Pharmaceutics, Inc. Pharmaceuticals: MajorHealth Technology Otologic Pharmaceutics, Inc. develops treatment for acute hearing loss. Its product HPN1010 is an oral medication to treat acute hearing loss to reduce the development of permanent hearing disorders. The company was founded by Richard Kopke, Robert A. Floyd and Dave karlman and is headquartered in Oklahoma City, OK. | Health Technology |